JCHOR

The Journal of Current Hematology & Oncology Research regularly publishes internationally qualified research in hematology and oncology within the current scholarly knowledge.

EndNote Style
ViewAll

Cover and Contents

Full Issue

Original Article - Oncology

Evaluation of treatment regimens and prognostic factors in primary central nervous system lymphomas

: 170 : 207

Citation : Akdeniz N, Ebinç S, Barışta İ, et al. Evaluation of treatment regimens and prognostic factors in primary central nervous system lymphomas. J Curr Hematol Oncol Res. 2025;3(3):49-56.

Original Article - Hematology

Ten-year journey with myelofibrosis: real-world data and clinical outcomes from a tertiary care center

: 19 : 347

Citation : Balık B, Akdeniz A, Koyuncu MB, et al. Ten-year journey with myelofibrosis: real-world data and clinical outcomes from a tertiary care center. J Curr Hematol Oncol Res. 2025;3(3):57-61.

Original Article - Hematology

Prognostic factors in diffuse large B cell lymphoma: a retrospective analysis from a tertiary center

: -51 : 368

Citation : Kahraman S, Doğan A, Çelik S, Esen R, Yıldırım Doğan N. Prognostic factors in diffuse large B cell lymphoma: a retrospective analysis from a tertiary center. J Curr Hematol Oncol Res. 2025;3(3):62-66.

Review - Hematology

The role of ELABELA in targeted treatment of acute myeloid leukaemia

: 204 : 139

Citation : Yanardağ Açık D, Karabulut ZT. The role of ELABELA in targeted treatment of acute myeloid leukemia. J Curr Hematol Oncol Res. 2025;3(3):67-73.

Case Report - Hematology

A rare case report: cytarabine-induced skin rash

: 39 : 254

Citation : Gülsar Çaycı MG, Satılmış O, Demircioğlu S, Tekinalp A. A rare case report: cytarabine-induced skin rash. J Curr Hematol Oncol Res. 2025;3(3):74-76.
_Footer